aTyr Pharma reported $34.92M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Ardelyx USD -9.78M 19.98M Jun/2026
aTyr Pharma USD 34.92M 34.95M Sep/2026
Biogen USD 450.8M 198.9M Jun/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Cipla INR 13.88B 154.2M Sep/2026
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -8.84M 180K Jun/2026
CSL USD 3.13B 1.17B Dec/2025
Curis USD -12.3M 231K Sep/2023
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Grifols EUR 482.04M 7.04M Sep/2025
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Novartis USD 8.62B 2.14B Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
United Therapeutics USD 334.2M 20.8M Sep/2026